Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee (Q48008162)
Jump to navigation
Jump to search
scientific article published on 15 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee |
scientific article published on 15 July 2015 |
Statements
1 reference
Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee (English)
1 reference
J J Cherian
1 reference
J Parvizi
1 reference
D Bramlet
1 reference
K H Lee
1 reference
D W Romness
1 reference
M A Mont
1 reference
15 July 2015
1 reference
23
1 reference
12
1 reference
2109-2118
1 reference
Identifiers
1 reference